Abstract
Background: Tonsillitis is widespread among children and has serious poststreptococcal complications. Clinicians often face the question of whether long-acting penicillin is a viable alternative to surgery. This study evaluates the effectiveness of tonsillectomy compared with long-acting penicillin in treating recurrent tonsillitis by comparing their effects on Antistreptolysin O Titer (ASOT) levels.
Methods: 100 patients aged 4-15 years with recurrent tonsillitis were divided into two groups of 50. Group one underwent tonsillectomy, while group two received monthly long-acting penicillin for 6 months. ASOT levels were recorded before and after the 6-month period.
Results: The mean ASOT for the tonsillectomy group dropped from 518.29 to 117.13 IU/ml (P < 0.004). For the penicillin group, it dropped from 526.70 to 262.98 IU/ml (P < 0.072).
Conclusions: Tonsillectomy is the effective first-line treatment for recurrent chronic tonsillitis in children. Long-acting penicillin remains a secondary option for patients with contraindications for surgery.
Introduction
Recurrent tonsillitis is a common pediatric ailment, but its implications extend beyond simple throat pain. Chronic infection by Streptococcus bacteria can lead to serious post-streptococcal complications, including rheumatic fever and glomerulonephritis.
Clinicians face a persistent dilemma: should they recommend surgical removal of the tonsils (tonsillectomy) or opt for long-term antibiotic prophylaxis? While surgery is definitive, it carries inherent risks. Conversely, long-term antibiotic use raises concerns about compliance and the discomfort of repeated injections. This study provides a quantitative comparison of these two paths by measuring their impact on ASOT levels—a blood marker indicating recent or ongoing streptococcal infection.
Methods and Data
The researchers conducted a prospective study involving 100 children (aged 4–15) at the Rajendra Institute of Medical Sciences in Ranchi, India. The cohort was divided into two groups:
- Tonsillectomy Group: Patients underwent standard surgical intervention.
- Penicillin Group: Patients received monthly intramuscular injections of benzathine penicillin G for six months.
The primary metric was the ASOT level, recorded at baseline and after six months. The study excluded patients with pre-existing conditions like anemia or bleeding disorders. The baseline mean ASOT for all patients was 522.49 IU/ml, significantly above the normal threshold of 200 IU/ml.
Key Results
The quantitative results showed a clear advantage for surgical intervention in normalizing immunological markers.
- Tonsillectomy Group: Mean ASOT levels dropped significantly from 518.29 IU/ml to 117.13 IU/ml ($P < 0.004$).
- Penicillin Group: Mean ASOT levels dropped from 526.70 IU/ml to 262.98 IU/ml ($P < 0.072$). While levels decreased, the drop was less dramatic and did not reach the standard significance threshold within the 6-month window.
As illustrated in the figure above, 43 out of 50 surgical patients (86%) achieved ASOT levels below the 200 IU/ml threshold, compared to only 15 out of 50 (30%) in the penicillin group.
Discussion and Insights
The most striking insight is the speed of "immunological recovery." Tonsillectomy appears to act as a physical "reset" for the immune system by removing the reservoir of bacteria, leading to a rapid decline in antibody production.
While penicillin is effective, its slower results and the discomfort of monthly injections make it better suited as a second-line treatment—specifically for children who have contraindications for surgery, such as bleeding diathesis. Interestingly, the study noted a strong parental preference for surgery, which sometimes influenced group retention.
Limitations
The authors acknowledge that the six-month follow-up is relatively short. Other research suggests that ASOT levels in non-surgical patients might take up to two years to normalize, suggesting a need for longer longitudinal studies. Additionally, larger multi-center trials would provide more robust data than this single-center cohort of 100 patients.
Conclusion
This study demonstrates that tonsillectomy is the preferred first-line treatment for recurrent chronic tonsillitis in children, as it is both clinically effective and provides a faster return to normal immunological markers. Long-acting penicillin remains a vital alternative for patients where surgery is not an option.
Summary updated